[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Markets Direct: Market Research Reports

Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.

A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.

The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.

With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.

Under the supervision of skillful managers and experts, business analysts produce reports that include:

  • Product portfolio
  • Potentially strong market reviews
  • Competitive analytics
  • Prospect partners
  • Mergers and acquisitions project data
  • Latest trends across a particular industry area
  • Research and development strategies
  • The analysis of new customers
  • A set of remedial measures for projects

They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.

Publications found: 2,030
Sort by:
Kaposi Sarcoma - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Kaposi Sarcoma (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Kaposi Sarcoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

March 2020 294 pages
Dyslipidemia - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Dyslipidemia (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Dyslipidemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

March 2020 372 pages
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H1 2020 US$ 2,500.00

... The Human Immunodeficiency Virus (HIV) Infections (AIDS) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Human Immunodeficiency Virus (HIV) Infections (AIDS) and features dormant and discontinued projects. The guide covers therapeutics under Development ...

March 2020 1202 pages
Arrhythmias - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Arrhythmias (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Arrhythmias and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

February 2020 87 pages
Viral Conjunctivitis - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Viral Conjunctivitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Viral Conjunctivitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

February 2020 50 pages
Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Congestive Heart Failure (Heart Failure) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

February 2020 558 pages
Alzheimer's Disease - Pipeline Review, H1 2020 US$ 2,500.00

... . The Alzheimer's Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Alzheimer's Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

February 2020 1716 pages
Atrial Fibrillation - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Atrial Fibrillation (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Atrial Fibrillation and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

February 2020 127 pages
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2020 US$ 2,000.00

... . The Attention Deficit Hyperactivity Disorder (ADHD) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Attention Deficit Hyperactivity Disorder (ADHD) and features dormant and discontinued projects. The guide covers therapeutics under Development ...

February 2020 178 pages
Diabetic Gastroparesis - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Diabetic Gastroparesis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Gastroparesis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

February 2020 72 pages
Drug Addiction - Pipeline Review, H1 2020 US$ 2,000.00

... . The Drug Addiction (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Drug Addiction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

February 2020 221 pages
Duchenne Muscular Dystrophy - Pipeline Review, H1 2020 US$ 2,000.00

... . The Duchenne Muscular Dystrophy (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Duchenne Muscular Dystrophy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

February 2020 381 pages
Epilepsy - Pipeline Review, H1 2020 US$ 2,000.00

... . The Epilepsy (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Epilepsy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

February 2020 605 pages
Genital Herpes - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Genital Herpes (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Genital Herpes and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

February 2020 116 pages
Myocardial Ischemia - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Myocardial Ischemia (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Myocardial Ischemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

February 2020 88 pages
Nasopharyngeal Cancer - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Nasopharyngeal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Nasopharyngeal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

February 2020 688 pages
Oral Mucositis - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Oral Mucositis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Oral Mucositis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

February 2020 128 pages
Osteoarthritis - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Osteoarthritis (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Osteoarthritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

February 2020 345 pages
Rectal Cancer - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Rectal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Rectal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

February 2020 202 pages
Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2020 US$ 2,000.00

... . The Spinal Muscular Atrophy (SMA) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Spinal Muscular Atrophy (SMA) and features dormant and discontinued projects. The guide covers therapeutics under Development ...

February 2020 167 pages
Candidiasis - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Candidiasis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Candidiasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

February 2020 204 pages
Cough - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Cough (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Cough and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

February 2020 112 pages
Diabetic Nephropathy - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Diabetic Nephropathy (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Nephropathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

February 2020 264 pages
Ocular Hypertension - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Ocular Hypertension (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Ocular Hypertension and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

February 2020 145 pages
African Trypanosomiasis - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The African Trypanosomiasis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for African Trypanosomiasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

February 2020 63 pages
Cat Allergy - Pipeline Review, H1 2020 US$ 2,000.00

... pipeline guide Cat Allergy - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Cat Allergy (Immunology), complete with analysis by stage of development ...

February 2020 31 pages
Polycythemia Vera - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Polycythemia Vera (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Polycythemia Vera and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

February 2020 129 pages
B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The B-Cell Chronic Lymphocytic Leukemia (Oncology) pipeline guide also reviews of key players involved in therapeutic development for B-Cell Chronic Lymphocytic Leukemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

February 2020 211 pages
Bronchopulmonary Dysplasia - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Bronchopulmonary Dysplasia (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Bronchopulmonary Dysplasia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

February 2020 76 pages
Burns - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Burns (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Burns and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

February 2020 108 pages
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2020 US$ 2,000.00

... Idiopathic Thrombocytopenic Purpura (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) and features dormant and discontinued projects. The guide covers therapeutics under Development ...

February 2020 163 pages
Osteosarcoma - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Osteosarcoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Osteosarcoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

February 2020 726 pages
Pruritus - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Pruritus (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Pruritus and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

February 2020 207 pages
Blepharitis - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Blepharitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Blepharitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

February 2020 61 pages
Encephalomyelitis - Pipeline Review, H1 2020 US$ 2,000.00

... . The Encephalomyelitis (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Encephalomyelitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

February 2020 65 pages
Fabry Disease - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Fabry Disease (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Fabry Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

February 2020 112 pages
Grass Pollen Allergy - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Grass Pollen Allergy (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Grass Pollen Allergy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

February 2020 78 pages
Liver Cirrhosis - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Liver Cirrhosis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Liver Cirrhosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

February 2020 149 pages
Dementia - Pipeline Review, H1 2020 US$ 2,000.00

... . The Dementia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Dementia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

February 2020 469 pages
Thalassemia - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Thalassemia (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Thalassemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

February 2020 198 pages
Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2020 US$ 2,000.00

... Juvenile Macular Degeneration (Stargardt Disease) (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Juvenile Macular Degeneration (Stargardt Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

February 2020 106 pages
Periodontitis - Pipeline Review, H1 2020 US$ 2,000.00

... And Dental Disorders) pipeline guide also reviews of key players involved in therapeutic development for Periodontitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

February 2020 58 pages
Restenosis - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Restenosis (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Restenosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

February 2020 62 pages
Seborrhea - Pipeline Review, H1 2020 US$ 2,000.00

... pipeline guide Seborrhea - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Seborrhea (Dermatology), complete with analysis by stage of development ...

February 2020 50 pages
Batten Disease - Pipeline Review, H1 2020 US$ 2,000.00

... . The Batten Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Batten Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

February 2020 92 pages
Activin Receptor Type 1 - Pipeline Review, H1 2020 US$ 3,500.00

... releases. The Actinic (Solar) Keratosis (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Actinic (Solar) Keratosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

February 2020 70 pages
Cryptococcosis - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Cryptococcosis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Cryptococcosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

February 2020 58 pages
Gonorrhea - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Gonorrhea (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Gonorrhea and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

February 2020 114 pages
Myocarditis - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Myocarditis (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Myocarditis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

February 2020 48 pages
Proliferative Vitreoretinopathy (PVR) - Pipeline Review, H1 2020 US$ 2,000.00

... pipeline guide Proliferative Vitreoretinopathy (PVR) – Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Proliferative Vitreoretinopathy (PVR) (Ophthalmology), complete with analysis by stage of development ...

February 2020 37 pages

Filters

Search

Categories

934
403
590
51
6
2
12
1
1
2
3
6
1
1
5
11
1

Publishers

2,030

Regions

2,030

Price

Date

Pages

Offers